Alkynyl derivatives as modulators of metabotropic glutamate receptors
US8674106B2 · kind B2 · utility
1Cited by
4References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 13, 2012 |
| Grant date | Mar 18, 2014 |
| Priority date | — |
| Expiry date | Jul 13, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds of formula I wherein W, n, X and W′ are defined in the description; invention compounds are modulators of metabotropic glutamate receptors—subtype 5 (“mGluR5”) which are useful for the treatment of central nervous system disorders as well as other disorders modulated by mGluR5 receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.